Please login to the form below
Cello Health BioConsulting appoints Jim Hall as president
Senior pharma marketer to preside over newly-formed consulting firm
Cello Health BioConsulting has appointed senior pharma marketer Jim Hall as president.
Hall joins with over 20 years of experience in the life sciences industry and, prior to joining Cello Health BioConsulting, was senior VP of Campbell Alliance's Corporate Development Practice and senior partner at Oliver Wyman in the health and life science practice.
Jon Bircher, global CEO of Cello Health consulting, said: “Jim brings an unparalleled knowledge and understanding of the US and global market, of great quality consulting and is the perfect person to lead the bioconsulting team, helping expand Cello Health's footprint in the United States and beyond.”
Julia Ralston, CEO of Cello Health US, added: “He will drive our expansion, not only working with our growing team of strong consultants as leading advisors to the bio-pharmaceutical and healthcare sector, but also contributing to our overarching Cello Health strategy.”
Hall will be based at the firm's Boston office and is the second recent hire for Cello Health BioConsulting.
COVID-19 Updates and Daily News
Featured jobs
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Account Director
-
£Competitive Salary
-
Account Manager (PR)
-
Great Benefits
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Manager
-
£Competitive Salary
- Sanofi doses first patient in global Kevzara COVID-19 trial
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- MHRA raises concerns over fraudulent coronavirus tests
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in UK
- Novartis donates malaria drug for COVID-19 clinical trials
- Making a difference with patient support
- Servier agrees to buy Symphogen to swell its cancer pipeline
- A Renewed Love of the NHS and National Recovery of the Patient-Doctor Relationship
- GSK and Vir Biotech join forces for COVID-19 antibodies
- Coronavirus causes Cancer Research UK to slash funding by £44m
- EMA backs compassionate use of Gilead’s remdesivir for COVID-19
PMHub
Onyx Health Ltd
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...
Latest intelligence
- What challenges still face clinical trial recruitment and retention?
- Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
- “Fake News” and Credibility in Medical Publishing
- Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
- Delivering true value: what does it mean for KAM in cancer care?
- Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Quick links
Infographics
